News Focus
News Focus
Followers 2
Posts 736
Boards Moderated 0
Alias Born 05/16/2017

Re: Biotech Pharmer post# 11738

Sunday, 10/01/2017 3:39:14 AM

Sunday, October 01, 2017 3:39:14 AM

Post# of 20617
The ANDA is at the FDA. Makes sense, doesn't it?

With forward looking statements there can hardly be a lie. Compared to the duration it took the FDA to the approve the fluticasone ANDAs of competitors, Dr Damaj had all right to assume a response by the FDA was imminent. When will you understand this?

Likewise, it's not a lie to miss revenue guidance. It's very hard to make revenue projections for a company with a new product lineup as there is hardly any stable historical data to base projections on. If missing projection is a lie to you, you shouldn't even invest in fortune 500 companies. Missing revenue projections is part of the normal investment game.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today